Tributylmethylammonium

Tributylmethylammonium

SCHEMBL306587

CCCC[N+](C)(CCCC)CCCC.COS(=O)(=O)[O-]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of Tributylmethylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.41
GLA P06280 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
EPHX2 P34913 1/20 0.41
BLM P54132 1/20 0.41
POLB P06746 2/20 0.37
BBOX1 O75936 3/20 0.36
SLC22A1 O15245 1/20 0.35
DNM1 Q05193 4/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
GRK2 P25098 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
LSS P48449 1/20 0.33
FUT7 Q11130 1/20 0.32
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11291479 0.94 RECQL (0.44) RECQLGLAHPGDTSHRMAPK1
SCHEMBL11290328 0.92 RECQL (0.47) RECQLGLAHPGDTSHRMAPK1
SCHEMBL4665831 0.92 RECQL (0.47) RECQLGLAHPGDTSHRMAPK1
SCHEMBL6708024 0.92 RECQL (0.47) RECQLGLAHPGDTSHRMAPK1
SCHEMBL2995385 0.92 RECQL (0.47) RECQLGLAHPGDTSHRMAPK1
SCHEMBL10588897 0.92 RECQL (0.47) RECQLGLAHPGDTSHRMAPK1
Tributylmethylammonium SCHEMBL22494154 0.87 RECQL (0.41) RECQLGLAHPGDTSHRMAPK1
Tributylmethylammonium SCHEMBL22494155 0.87 RECQL (0.41) RECQLGLAHPGDTSHRMAPK1
SCHEMBL3412306 0.86 POLB (0.39) RECQLGLAHPGDTSHRMAPK1
Tributylmethylammonium SCHEMBL1627725 0.86 BBOX1 (0.41) RECQLGLAHPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 703 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705547-A1 PROCESS FOR THE PREPARATION OF 1,1,4,4-TETRAALKYLOXY-2-BUTENE DSM IP Assets B.V. (NL) 2026-03-11 EP claimed
EP-4703496-A1 ETCHING COMPOSITION COMPRISING AT LEAST ONE IONIC LIQUID AND AT LEAST ONE LACTAMIDE AND PROCESS FOR COATING PLASTIC SURFACES WITH METALS BY USING THE SAME BASF SE (DE) 2026-03-04 EP claimed
US-20250353823-A1 PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN DSM IP ASSETS BV (NL) 2025-11-20 US claimed
EP-3275039-B1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF CORP (US) 2025-08-27 EP claimed
EP-4540440-A1 PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN DSM IP Assets B.V. (NL) 2025-04-23 EP claimed
CN-119823109-A An electrochromic material electrochromic composition and electrochromic device 吉林大学 2025-04-15 CN claimed
CN-119403790-A Process for preparing hydroxyphenyl-1, 3, 5-triazine compounds 巴斯夫欧洲公司 2025-02-07 CN claimed
CN-119365631-A Process for preparing alkoxylated 2, 5-dihydrofurans 帝斯曼知识产权资产管理有限公司 2025-01-24 CN claimed
WO-2024231257-A1 PROCESS FOR THE PREPARATION OF 1,1,4,4-TETRAALKYLOXY-2-BUTENE DSM IP ASSETS B.V. (NL) 2024-11-14 WO claimed
US-12012429-B2 Renewable aromatics from lignocellulosic lignin NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) 2024-06-18 US claimed
US-20100279372-A1 METHOD OF PRETREATING LIGNOCELLULOSE-BASED BIOMASS SAMSUNG ELECTRONICS CO., LTD. (KR) 2010-11-04 US claimed
WO-2010108874-A1 ELECTROCHEMICAL METHOD FOR PRODUCING 3 TERT.-BUTYL BENZALDEHYDE- DIMETHYLACETAL BASF SE (DE) 2010-09-30 WO claimed
US-20100095703-A1 Novel Working Media for Refrigeration Processes EVONIK DEGUSSA GMBH (DE) 2010-04-22 US claimed
US-20090029880-A1 Composition containing lonic liquid clay stabilizers and/or shale inhibitors and method of using the same BJ SERVICES COMPANY 2009-01-29 US claimed
US-20090014123-A1 Adhesive composition and optical member Wuxi Hengxin Optoelectronic Materials Co., Ltd. (CN) 2009-01-15 US claimed
EP-1893716-A1 NOVEL WORKING MEDIA FOR REFRIGERATION PROCESSES Evonik Degussa GmbH (DE) 2008-03-05 EP claimed
WO-2006134015-A1 NOVEL WORKING MEDIA FOR REFRIGERATION PROCESSES EVONIK DEGUSSA GMBH (DE) 2006-12-21 WO claimed
EP-1514955-B1 Method for distilling an electrolyte containing tmof BASF AG (DE) 2006-05-31 EP claimed
EP-1514955-A1 Method for distilling an electrolyte containing tmof BASF Aktiengesellschaft (DE) 2005-03-16 EP claimed
US-4112065-A Compositions of bis(ortho-substituted phenyl)carbodiimides and quaternary ammonium salts and their use thereof in combatting ectoparasitic tick infestations of animals BAYER AKTIENGESELLSCHAFT (GE) 1978-09-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250353823-A1 PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN CYP4F2, CYP4F12, CYP2F1 RECQL 3087/4885GLA 2271/4885HPGD 286/4885
US-12012429-B2 Renewable aromatics from lignocellulosic lignin DCXR, ALG1, AGL RECQL 1522/4885GLA 484/4885HPGD 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.